首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1629883

全球家庭醫療保健設備市場 - 2025-2033

Global Home Healthcare Devices Market - 2025-2033

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球家庭醫療保健設備市場規模達到462.5億美元，預計2033年將達到822.7億美元，2025-2033年預測期間複合年成長率為6.8%。

家庭醫療保健設備是個人可以在家中使用來管理其健康狀況的一組醫療設備和技術。個人可以使用這些設備來監測和治療各種醫療問題，而無需定期前往醫療機構，從而支持更舒適、更方便的醫療保健方法。對家庭護理的需求不斷成長反映了醫療保健領域的一個更大趨勢，即人們希望在獲得必要醫療的同時保持獨立性。

患者對家庭治療的需求增加是預測期內推動市場的促進因素。有幾個因素促成了家庭醫療保健的發展，包括人口老化、慢性病盛行率的增加以及醫療技術的發展提高了家庭護理的可行性和有效性。

市場動態：

驅動程式和限制

患者對家庭治療的需求增加

患者對家庭治療的需求增加預計將成為全球家庭醫療設備市場成長的重要因素。這一趨勢主要是由幾個相互關聯的因素推動的，包括人口老化、慢性病盛行率上升、技術進步、在促進有效家庭護理的設備中引入人工智慧。由於老年人的特殊醫療保健需求，不斷擴大的老年人口對全球家庭醫療設備市場產生了重大影響。隨著年齡的成長，他們更有可能患上需要持續醫療和監測的慢性疾病。

老年人口的增加是家庭治療需求增加的主要原因之一。例如，據世界衛生組織稱，到2050年，80%的老年人將生活在低收入和中等收入國家。人口老化的速度比過去快得多。 2020年，60歲及以上的人口數量超過了5歲以下的兒童數。 2015年至2050年間，全球60歲以上人口比例將增加近一倍，從12%增加至22%。到 2030 年，世界上每 6 人就有 1 人年齡在 60 歲或以上。

各種設備的技術進步、最近的推出以及 FDA 的批准推動了市場的發展。例如，2024 年 11 月，美敦力 (Medtronic) 的新型 InPen 智慧型手機軟體獲得美國食品藥物管理局 (FDA) 批准，並宣布發布全新 Smart MDI 系統。 Smart MDI 旨在為使用者提供有關每日多次注射 (MDI) 治療的即時資訊。

此外，2024 年9 月，雅培實驗室(Abbott Laboratories) 宣布其非處方連續血糖監測儀Lingo 在美國上市。會出現血糖峰值。

設備成本高

設備成本高等因素預計將阻礙全球家庭醫療設備市場。醫療器材的高成本是潛在消費者的主要擔憂。許多家庭保健產品，如胰島素幫浦、霧化器和先進的監測系統，價格昂貴，可能會阻礙患者購買。在此類設備的保險覆蓋範圍較低或不存在的地區尤其如此，需要患者自行承擔全部費用。例如，胰島素輸送系統的平均價格為 3,000 美元至 6,000 美元。這凸顯了人們在使用這些重要設備時所承受的巨大成本負擔。

Home healthcare devices are a set of medical devices and technologies that individuals can use at home to manage their health conditions. Individuals can use these devices to monitor and treat a variety of medical concerns without having to make regular visits to healthcare institutions, supporting a more comfortable and convenient approach to healthcare. The growing demand for home-based care reflects a larger trend in the healthcare sector, in which people want to keep their independence while obtaining necessary medical treatment.

The increased patient demand for home-based treatments is the driving factor that drives the market over the forecast period. Several factors contribute to this move toward home healthcare, including an aging population, an increase in the prevalence of chronic diseases, and developments in medical technology that improve the feasibility and effectiveness of home-based care.

Market Dynamics: Drivers & Restraints

Increased patient demand for home-based treatments

The increased patient demand for home-based treatments is expected to be a significant factor in the growth of the global home healthcare devices market. This trend is primarily fueled by several interconnected factors, including the aging population, the rising prevalence of chronic diseases, and advancements in technology, introduction of artificial intelligence in the devices that facilitate effective care at home. The expanding geriatric population has a substantial impact on the global home medical equipment market, owing to older persons' specific healthcare needs. As people age, they are more likely to develop chronic diseases that require continuing medical treatment and monitoring.

The increase in the geriatric population is one of the major reasons for the increasing demand of the home-based treatment. For instance, according to WHO, in 2050, 80% of older people will be living in low- and middle-income countries. The pace of population aging is much faster than in the past. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. By 2030, 1 in 6 people in the world will be aged 60 years or over.

The technological advancements, recent launches, and FDA approvals of various devices drives the market. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy.

Moreover, in September 2024, Abbott Laboratories announced that its over-the-counter continuous glucose monitor Lingo is available in the U.S. One of Abbott's primary goals is to help Lingo users learn about glucose spikes, which occur when the amount of sugar present in the bloodstream rapidly increases and then decreases.

High costs of devices

Factors such as high costs of devices are expected to hamper the global home healthcare devices market. The high cost of medical devices is a major concern for potential consumers. Many home healthcare products, such as insulin pumps, nebulizers, and advanced monitoring systems, come with high prices that may hinder patients from purchasing them. This is especially true in areas where insurance coverage for such devices is low or non-existent, requiring patients to face the entire expense themselves. For instance, the average price of the insulin delivery system ranges from $3,000 to $ 6,000. This highlights the substantial cost burden that people suffer when using these vital devices.

Segment Analysis

The global home healthcare devices market is segmented based on therapeutic devices, monitoring devices, mobility care devices, distribution channels, and region.

Monitoring devices segment is expected to dominate the global home healthcare devices market share

The monitoring devices segment is anticipated to dominate the global home healthcare devices market. The monitoring devices segment is expected to lead the worldwide home healthcare devices market due to several interconnected variables that represent the changing face of healthcare. As chronic diseases become more common, there is an increased demand for ongoing health monitoring, particularly among older persons and those with long-term health concerns. This shift toward proactive health management stresses the relevance of patient monitoring devices, which enable people to follow vital signs and other health metrics from home, allowing for more prompt interventions and lowering the need for hospital visits.

For instance, in August 2024, Dexcom announced the launch of an over-the-counter continuous glucose monitor. Dexcom's Stelo monitors blood glucose levels constantly via a wearable sensor and an application on the user's smartphone or other smart device. Moreover, in June 2024, Prevounce Health, a leading provider of remote care management software, devices, and services, announced the launch of its first remote blood glucose monitoring device, Pylo GL1-LTE. The blood glucose meter has been scientifically tested and linked to numerous cellular networks to guarantee more dependable data transmission across the United States. The GL1-LTE is compatible with the Prevounce remote care management platform and may be integrated with other health software using the Pylo cloud API. Prevounce's Pylo cellular-connected gadgets include blood pressure monitors and weight scales.

Geographical Analysis

North America is expected to hold a significant position in the global home healthcare devices market share

North America is expected to hold a significant portion of the global home healthcare devices market. North America will likely dominate the global home healthcare devices market, owing to a combination of demographic, economic, and technical factors. The region benefits from a well-established healthcare infrastructure that encourages the use of home healthcare solutions. As the geriatric population and frequency of chronic diseases increases, so does the demand for home medical equipment that enables patients to properly manage their health conditions from the comfort of their own homes. This trend to home-based treatment not only improves patient comfort but also decreases the pressure on healthcare facilities, making it a popular choice among many individuals and families.

For instance, according to urban.org, the number of Americans aged 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The number of adults ages 85 and older, the group most often needing help with basic personal care, will nearly quadruple between 2000 and 2040. For an instance, according to America Health Ranking.org, 17.3% of the entire US population is geriatric population.

There are major players present in this region which makes this region the most dominating. For instance, in November 2024, Medtronic received U.S. Food and Drug Administration (FDA) approval for its new InPen smartphone software and announced the release of its new Smart MDI system. Smart MDI was created to give users real-time information about multiple daily injection (MDI) therapy.

Asia Pacific is growing at the fastest pace in the global home healthcare devices market

The Asia Pacific region is emerging as the fastest-growing market for home healthcare devices. One of the major contributions to this growth is the rising prevalence of chronic diseases in the population and the increasing geriatric population. Diabetes, cardiovascular diseases, and respiratory ailments are growing increasingly prevalent as people's lifestyles change and urbanization accelerates. The rise in chronic diseases demands continual monitoring and management, making home medical devices crucial for individuals who prefer to manage their health at home rather than visit healthcare facilities.

The increasing geriatric population is one of the driving factors in this region making it the fastest growing region. For instance, according to the UNFPA India, the current elderly population of 153 million (aged 60 and above) is expected to reach a staggering 347 million by 2050.

Competitive Landscape

The major global players in the global home healthcare devices market include Invacare Corporation, Karman Healthcare Inc., Ottobock, Pride Mobility Products Corp., Medtronic, Sunrise Medical, Meyra GmbH, Koninklijke Philips N.V., Nihon Kohden Corporation, Danaher Corporation among others.

Emerging Players

Livongo, Tyto Care, and iRhythm Tech among others

Key Developments

In August 2024, Hong Kong-based health tech start-up Libpet introduced its innovative smart robot wheelchairs, designed not only for the physically challenged but for everyone. By reducing physical effort, the inclusive device enhances mobility and productivity, making life significantly easier.
In November 2023, DuPont announced a collaboration between DuPont Liveo Healthcare Solutions and STMicroelectronics, a global leader in semiconductor technology. Together, they are working on the development of a new smart wearable device concept aimed at remote biosignal monitoring.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global home healthcare devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Therapeutic Devices
3.2. Snippet by Monitoring Devices
3.3. Snippet by Mobility Care Devices
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increased Patient Demand For Home-based Treatments
- 4.1.3. Restraints
- 4.1.4. High Cost of Medical Equipment
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Therapeutic Devices

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Devices
- 6.1.2. Market Attractiveness Index, By Therapeutic Devices
6.2. Insulin Delivery Systems*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Home Dialysis Machines
6.4. Respiratory Devices
6.5. Others

7. By Monitoring Devices

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 7.1.2. Market Attractiveness Index, By Monitoring Devices
7.2. Blood Glucose Meters*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blood Pressure Monitors
7.4. Temperature Monitoring Devices
7.5. Pulse Oximeters
7.6. Others

8. By Mobility Care Devices

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 8.1.2. Market Attractiveness Index, By Mobility Care Devices
8.2. Wheelchairs*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Walkers
8.4. Mobility Scooters
8.5. Others

9. By Distribution Channel

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Hospital Pharmacies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Retail Pharmacies
9.4. Online Pharmacies

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.2.8. The U.S.
- 10.2.9. Canada
- 10.2.10. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.3.8. Germany
- 10.3.9. UK
- 10.3.10. France
- 10.3.11. Italy
- 10.3.12. Spain
- 10.3.13. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.8. Brazil
- 10.4.9. Argentina
- 10.4.10. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.8. China
- 10.5.9. India
- 10.5.10. Japan
- 10.5.11. South Korea
- 10.5.12. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), Therapeutic Devices
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Monitoring Devices
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mobility Care Devices
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Invacare Corporation*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Karman Healthcare Inc.
12.3. Ottobock
12.4. Pride Mobility Products Corp.
12.5. Medtronic
12.6. Sunrise Medical
12.7. Meyra GmbH
12.8. Koninklijke Philips N.V.
12.9. Nihon Kohden Corporation
12.10. Danaher Corporation

LIST NOT EXHAUSTIVE